Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaaT033 in AlloHCT (PHOEBUS)
NCT05762211Phase 2Recruiting
- Sponsor
- MaaT Pharma
- Start
- Oct 2023
- Primary completion
- Oct 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 6
01
Overview
A Phase 2 trial of MaaT-033 in Transplant-related complications, sponsored by MaaT Pharma. Started Oct 2023; status: recruiting.
02
Drugs
MaaT-033
03
Conditions
Transplant-related complications
Beyond the preview
Go deeper on NCT05762211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05762211.